» Articles » PMID: 31287721

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes

Abstract

Continuous glucose monitoring (CGM) has potential to address challenges of type 1 diabetes (T1D) management for young children. CGM use is increasing, yet remains underutilized. Characterizing parents' experiences with CGM can inform clinical strategies to help parents make decisions about diabetes management, overcome obstacles to initiating and sustaining CGM use, and maximize benefits of CGM use in their children's diabetes care. Transcripts from semistructured qualitative interviews with 55 parents of children aged 1 to <8 years, with T1D duration ≥6 months, and whose child currently or previously used CGM were coded and analyzed to derive themes about their experiences with CGM. Participants were 88% mothers and the mean child age was 5.0 ± 1.5 years. Parents described benefits of CGM use: decreased worry about glucose excursions, improved sleep, increased sense of safety with children who cannot recognize or express symptoms of hypo- or hyperglycemia, and greater comfort with other caregivers, especially using remote monitoring functionality when away from children. Challenges included painful insertions, wearing multiple devices on small bodies, disruptive alerts, data gaps due to lost signals, skin/adhesive problems, and difficulty interpreting the amount of information generated by CGM. For some, the challenges outweighed potential benefits and they stopped CGM use. CGM may address unique challenges of T1D in young children and increase parental comfort with diabetes management, yet there are multiple barriers to initiating or maintaining CGM use. Education and behavioral support to address these benefits and barriers may equip caregivers with skills to address challenges of CGM use.

Citing Articles

Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making.

Mohamad N, Abdullah Sani A, Ahmad Nizam N, Sze-Shir F, Mohamed Ghazali I, Sarimin R Int J Technol Assess Health Care. 2025; 41(1):e13.

PMID: 39910989 PMC: 11894388. DOI: 10.1017/S0266462325000078.


International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

Tauschman M, Cardona-Hernandez R, DeSalvo D, Hood K, Laptev D, Lindholm Olinder A Horm Res Paediatr. 2025; 97(6):615-635.

PMID: 39884260 PMC: 11854985. DOI: 10.1159/000543156.


The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions.

Esposito S, Sambati V, Fogliazza F, Street M, Principi N Front Endocrinol (Lausanne). 2025; 15:1513166.

PMID: 39758346 PMC: 11695225. DOI: 10.3389/fendo.2024.1513166.


Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review.

Podwojniak A, Flemming J, J Tan I, Ghani H, Neubauer Z, Jones A JMIR Dermatol. 2024; 7:e59824.

PMID: 39622650 PMC: 11587996. DOI: 10.2196/59824.


Parental experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes: a qualitative interview study.

Roberts A, Tully A, Binkowski S, Bebbington K, Penno M, Anderson A Front Clin Diabetes Healthc. 2024; 5:1479948.

PMID: 39611061 PMC: 11602481. DOI: 10.3389/fcdhc.2024.1479948.


References
1.
Iturralde E, Tanenbaum M, Hanes S, Suttiratana S, Ambrosino J, Ly T . Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. Diabetes Educ. 2017; 43(2):223-232. PMC: 7162535. DOI: 10.1177/0145721717697244. View

2.
Streisand R, Monaghan M . Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep. 2014; 14(9):520. PMC: 4113115. DOI: 10.1007/s11892-014-0520-2. View

3.
Van Name M, Hilliard M, Boyle C, Miller K, DeSalvo D, Anderson B . Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes. 2017; 19(1):114-120. PMC: 5650950. DOI: 10.1111/pedi.12525. View

4.
Wadwa R, Laffel L, Shah V, Garg S . Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018; 20(6):395-402. PMC: 6110124. DOI: 10.1089/dia.2018.0150. View

5.
Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M . A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012; 35(2):204-10. PMC: 3263860. DOI: 10.2337/dc11-1746. View